Sophie Pezet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sophie Pezet has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Mickael Tanter
Physics for Medicine, ESPCI, INSERM, CNRS, PSL University
12 shared publications Mickael Tanter
Physics for Medicine Paris, Inserm, ESPCI Paris, CNRS, PSL Research University - Paris, France
9 shared publicationsThomas Deffieux
Physics for Medicine Paris, Inserm, ESPCI Paris, CNRS, PSL Research University - Paris, France
9 shared publicationsNathalie Ialy-Radio
Physics for Medicine Paris, Inserm, ESPCI Paris, CNRS, PSL Research University, Paris, France
7 shared publicationsAlexandre Dizeux
Physics for Medicine Paris, Inserm, ESPCI Paris, CNRS, PSL Research University, Paris, France
6 shared publicationsBenoit Beliard
Physics for Medicine Paris, Inserm, ESPCI Paris, CNRS, PSL Research University, Paris, France
6 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Springer Nature in Communications Biology
Large-scale functional brain network organization is largely preserved in neuropathic pain despite selective circuit-level adaptations
- 23 September 2026
- Published by Springer Nature in Communications Biology
Open AccessLarge-scale functional brain network organization is largely preserved in neuropathic pain despite selective circuit-level adaptations
- Top Cited PapersOpen Access
- 15 July 2026
- Published by Springer Nature in Nature
- Vol. 656 (8127) , 390-398
A queen odour mediates reproductive suppression in a eusocial mammal
Eusociality is exceptionally rare in mammals, and its proximate mechanisms remain poorly understood. Naked mole-rats provide a striking example, with reproduction restricted to a single queen, while all other females remain infertile 1 . Here we identify a chemical signal in queens that can regulate this reproductive hierarchy. Isopropyl myristate is a low-volatility ester that is enriched in queens and nearly absent from non-breeding animals. Isopropyl myristate is detected by peripheral and central olfactory neurons and elicits avoidance in high-ranking animals. Exposure alters levels of prolactin and progesterone in non-breeders to suppress reproduction. Daily addition of isopropyl myristate to a queenless colony prevented queen succession, whereas withdrawal triggered aggression and reproductive competition. Isopropyl myristate was also detected in breeding females of several Fukomys mole-rat species, but reaches higher levels in naked mole-rats, paralleling their extreme reproductive skew. These findings reveal a chemical cue that can mediate reproductive suppression in a mammal, linking insect and mammalian eusociality.
- 15 July 2026
- Published by Springer Nature in Nature
- Vol. 656 (8127) , 390-398
Top Cited PapersOpen AccessA queen odour mediates reproductive suppression in a eusocial mammal
Eusociality is exceptionally rare in mammals, and its proximate mechanisms remain poorly understood. Naked mole-rats provide a striking example, with reproduction restricted to a single queen, while all other females remain infertile 1 . Here we identify a chemical signal in queens that can regulate this reproductive hierarchy. Isopropyl myristate is a low-volatility ester that is enriched in queens and nearly absent from non-breeding animals. Isopropyl myristate is detected by peripheral and central olfactory neurons and elicits avoidance in high-ranking animals. Exposure alters levels of prolactin and progesterone in non-breeders to suppress reproduction. Daily addition of isopropyl myristate to a queenless colony prevented queen succession, whereas withdrawal triggered aggression and reproductive competition. Isopropyl myristate was also detected in breeding females of several Fukomys mole-rat species, but reaches higher levels in naked mole-rats, paralleling their extreme reproductive skew. These findings reveal a chemical cue that can mediate reproductive suppression in a mammal, linking insect and mammalian eusociality.
- Open Access
- 3 March 2026
- Published by Springer Nature in Research Square
REM sleep drives cerebrospinal fluid efflux through massive mechanical and vascular surges
The glymphatic system clears metabolic waste through cerebrospinal fluid (CSF) transport in the brain parenchyma and is most active during sleep. Yet the physical mechanisms generating glymphatic flow remain unclear, particularly the contribution of rapid eye movement (REM) sleep. Reports of reduced CSF inflow during REM have suggested a minimal role, yet imaging methods have, to date, been unable to capture whole-brain, multiparametric brain dynamics across full sleep cycles. Here, we develop an original multiparametric functional imaging modality using ultrasound during natural sleep in rodents. Our approach simultaneously maps brain mechanical properties, vascular activity, morphological deformations and intraventricular CSF flow at high spatiotemporal resolution. We show that REM onset is marked by a rapid decrease in cortical and midbrain stiffness—indicative of extracellular fluid expansion—followed approximately fifteen seconds later by a large and sustained increase in cerebral blood volume and mesoscale tissue deformation during the full REM episode. These vascular and mechanical surges coincide with elevated CSF efflux through the cerebral aqueduct and ventricles. REM-associated dynamics far exceed cardiac and respiratory pulsations in generating tissue strain and CSF motion. Complementary to NREM sleep which has been shown to promote CSF inflow via perivascular pathways, our results show that REM sleep strongly drives efflux through vascular–mechanical coupling. By enabling simultaneous imaging of brain stiffness, mesoscopic strain, vascular activity and intraventricular CSF flow, multiparametric functional ultrasound imaging uncovers REM sleep as a pivotal biomechanical phase of brain clearance.
- 3 March 2026
- Published by Springer Nature in Research Square
Open AccessREM sleep drives cerebrospinal fluid efflux through massive mechanical and vascular surges
The glymphatic system clears metabolic waste through cerebrospinal fluid (CSF) transport in the brain parenchyma and is most active during sleep. Yet the physical mechanisms generating glymphatic flow remain unclear, particularly the contribution of rapid eye movement (REM) sleep. Reports of reduced CSF inflow during REM have suggested a minimal role, yet imaging methods have, to date, been unable to capture whole-brain, multiparametric brain dynamics across full sleep cycles. Here, we develop an original multiparametric functional imaging modality using ultrasound during natural sleep in rodents. Our approach simultaneously maps brain mechanical properties, vascular activity, morphological deformations and intraventricular CSF flow at high spatiotemporal resolution. We show that REM onset is marked by a rapid decrease in cortical and midbrain stiffness—indicative of extracellular fluid expansion—followed approximately fifteen seconds later by a large and sustained increase in cerebral blood volume and mesoscale tissue deformation during the full REM episode. These vascular and mechanical surges coincide with elevated CSF efflux through the cerebral aqueduct and ventricles. REM-associated dynamics far exceed cardiac and respiratory pulsations in generating tissue strain and CSF motion. Complementary to NREM sleep which has been shown to promote CSF inflow via perivascular pathways, our results show that REM sleep strongly drives efflux through vascular–mechanical coupling. By enabling simultaneous imaging of brain stiffness, mesoscopic strain, vascular activity and intraventricular CSF flow, multiparametric functional ultrasound imaging uncovers REM sleep as a pivotal biomechanical phase of brain clearance.
- Open Access
Temporal Patterns of Brain Network Plasticity During the Onset and Maintenance of Neuropathic Pain in Male Mice
Neuropathic pain arises from complex peripheral and central mechanisms and induces long-lasting maladaptive changes in the brain. To investigate the temporal dynamics of these changes, we examined resting-state functional connectivity (FC) in a mouse model of neuropathic pain across its initiation and maintenance phases. Using functional ultrasound imaging to capture whole-brain FC over disease progression, we conducted two complementary studies: a longitudinal assessment in anesthetized animals and an analysis of awake cohorts at distinct disease stages. Both exploratory and literature-guided analyses revealed that FC across most large-scale networks remained remarkably stable during pain maintenance. In contrast, pain onset was marked by enhanced FC between key regions involved in sensory, emotional, and motivational processing, including the motor cortex and nucleus accumbens, the prelimbic and insular cortices, and the infralimbic cortex and hypothalamus. As pain persisted, we observed reduced FC within the somatomotor network, reflecting functional disconnection. Additionally, postsurgical pain alone produced enduring FC changes within the prefrontal cortex, hippocampus, and insula, indicating long-term central plasticity independent of neuropathic injury. Together, these findings reveal dynamic, network-specific adaptations that distinguish the onset and maintenance phases of neuropathic pain and surgery-related plasticity.
Open AccessTemporal Patterns of Brain Network Plasticity During the Onset and Maintenance of Neuropathic Pain in Male Mice
Neuropathic pain arises from complex peripheral and central mechanisms and induces long-lasting maladaptive changes in the brain. To investigate the temporal dynamics of these changes, we examined resting-state functional connectivity (FC) in a mouse model of neuropathic pain across its initiation and maintenance phases. Using functional ultrasound imaging to capture whole-brain FC over disease progression, we conducted two complementary studies: a longitudinal assessment in anesthetized animals and an analysis of awake cohorts at distinct disease stages. Both exploratory and literature-guided analyses revealed that FC across most large-scale networks remained remarkably stable during pain maintenance. In contrast, pain onset was marked by enhanced FC between key regions involved in sensory, emotional, and motivational processing, including the motor cortex and nucleus accumbens, the prelimbic and insular cortices, and the infralimbic cortex and hypothalamus. As pain persisted, we observed reduced FC within the somatomotor network, reflecting functional disconnection. Additionally, postsurgical pain alone produced enduring FC changes within the prefrontal cortex, hippocampus, and insula, indicating long-term central plasticity independent of neuropathic injury. Together, these findings reveal dynamic, network-specific adaptations that distinguish the onset and maintenance phases of neuropathic pain and surgery-related plasticity.
- 15 November 2025
- Published by MyJove Corporation
- No. 225,p. e68612
JoVE Video Dataset
Ultrasound Localization Microscopy (ULM) is a super-resolution imaging technique that enables in vivo visualization of the brain's microvascular architecture surpassing the diffraction limit of conventional ultrasound. By detecting and tracking intravenously injected microbubbles as they circulate through cerebral vessels, ULM produces high-resolution maps of vascular density, flow velocity, and backscattered signal amplitude at spatial scales down to 5-10 µm. This protocol presents a complete workflow for performing ULM imaging in rodents, including animal preparation, probe positioning, image acquisition, microbubble injection, and data processing, using a dedicated functional ultrasound platform. Two preparation methods are described, adapted for mice (transcranial) and rats (with cranial windows), followed by detailed instructions for probe alignment and anatomical targeting using an integrated brain atlas. During acquisition, ultrafast ultrasound sequences are synchronized with bolus injections of microbubbles to capture dynamic flow data. Subsequent reconstruction steps involve clutter filtering, image interpolation, microbubble detection, subpixel localization, and trajectory tracking. Outputs include density maps reflecting vessel occupancy, velocity maps revealing flow patterns and directionality, and amplitude maps offering additional contrast for structural interpretation. Representative results illustrate successful acquisition across full coronal planes and highlight common pitfalls such as poor injection quality, motion artifacts, and skull-induced aberration. The protocol is compatible with both cross-sectional and longitudinal studies and is particularly suited for investigating cerebrovascular alterations in models of aging, stroke, aneurysm, and neurodegenerative diseases. By combining depth penetration, high spatiotemporal resolution, and label-free vascular imaging, ULM offers a powerful tool for noninvasive brain microcirculation analysis in preclinical models.
- 15 November 2025
- Published by MyJove Corporation
- No. 225,p. e68612
JoVE Video Dataset
Ultrasound Localization Microscopy (ULM) is a super-resolution imaging technique that enables in vivo visualization of the brain's microvascular architecture surpassing the diffraction limit of conventional ultrasound. By detecting and tracking intravenously injected microbubbles as they circulate through cerebral vessels, ULM produces high-resolution maps of vascular density, flow velocity, and backscattered signal amplitude at spatial scales down to 5-10 µm. This protocol presents a complete workflow for performing ULM imaging in rodents, including animal preparation, probe positioning, image acquisition, microbubble injection, and data processing, using a dedicated functional ultrasound platform. Two preparation methods are described, adapted for mice (transcranial) and rats (with cranial windows), followed by detailed instructions for probe alignment and anatomical targeting using an integrated brain atlas. During acquisition, ultrafast ultrasound sequences are synchronized with bolus injections of microbubbles to capture dynamic flow data. Subsequent reconstruction steps involve clutter filtering, image interpolation, microbubble detection, subpixel localization, and trajectory tracking. Outputs include density maps reflecting vessel occupancy, velocity maps revealing flow patterns and directionality, and amplitude maps offering additional contrast for structural interpretation. Representative results illustrate successful acquisition across full coronal planes and highlight common pitfalls such as poor injection quality, motion artifacts, and skull-induced aberration. The protocol is compatible with both cross-sectional and longitudinal studies and is particularly suited for investigating cerebrovascular alterations in models of aging, stroke, aneurysm, and neurodegenerative diseases. By combining depth penetration, high spatiotemporal resolution, and label-free vascular imaging, ULM offers a powerful tool for noninvasive brain microcirculation analysis in preclinical models.
- 14 November 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 225,p. e68612
Ultrasound Localization Microscopy for Super-Resolution Mapping of the Rodent Brain Microvasculature
Ultrasound Localization Microscopy (ULM) is a super-resolution imaging technique that enables in vivo visualization of the brain's microvascular architecture surpassing the diffraction limit of conventional ultrasound. By detecting and tracking intravenously injected microbubbles as they circulate through cerebral vessels, ULM produces high-resolution maps of vascular density, flow velocity, and backscattered signal amplitude at spatial scales down to 5-10 µm. This protocol presents a complete workflow for performing ULM imaging in rodents, including animal preparation, probe positioning, image acquisition, microbubble injection, and data processing, using a dedicated functional ultrasound platform. Two preparation methods are described, adapted for mice (transcranial) and rats (with cranial windows), followed by detailed instructions for probe alignment and anatomical targeting using an integrated brain atlas. During acquisition, ultrafast ultrasound sequences are synchronized with bolus injections of microbubbles to capture dynamic flow data. Subsequent reconstruction steps involve clutter filtering, image interpolation, microbubble detection, subpixel localization, and trajectory tracking. Outputs include density maps reflecting vessel occupancy, velocity maps revealing flow patterns and directionality, and amplitude maps offering additional contrast for structural interpretation. Representative results illustrate successful acquisition across full coronal planes and highlight common pitfalls such as poor injection quality, motion artifacts, and skull-induced aberration. The protocol is compatible with both cross-sectional and longitudinal studies and is particularly suited for investigating cerebrovascular alterations in models of aging, stroke, aneurysm, and neurodegenerative diseases. By combining depth penetration, high spatiotemporal resolution, and label-free vascular imaging, ULM offers a powerful tool for noninvasive brain microcirculation analysis in preclinical models.
- 14 November 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 225,p. e68612
Ultrasound Localization Microscopy for Super-Resolution Mapping of the Rodent Brain Microvasculature
Ultrasound Localization Microscopy (ULM) is a super-resolution imaging technique that enables in vivo visualization of the brain's microvascular architecture surpassing the diffraction limit of conventional ultrasound. By detecting and tracking intravenously injected microbubbles as they circulate through cerebral vessels, ULM produces high-resolution maps of vascular density, flow velocity, and backscattered signal amplitude at spatial scales down to 5-10 µm. This protocol presents a complete workflow for performing ULM imaging in rodents, including animal preparation, probe positioning, image acquisition, microbubble injection, and data processing, using a dedicated functional ultrasound platform. Two preparation methods are described, adapted for mice (transcranial) and rats (with cranial windows), followed by detailed instructions for probe alignment and anatomical targeting using an integrated brain atlas. During acquisition, ultrafast ultrasound sequences are synchronized with bolus injections of microbubbles to capture dynamic flow data. Subsequent reconstruction steps involve clutter filtering, image interpolation, microbubble detection, subpixel localization, and trajectory tracking. Outputs include density maps reflecting vessel occupancy, velocity maps revealing flow patterns and directionality, and amplitude maps offering additional contrast for structural interpretation. Representative results illustrate successful acquisition across full coronal planes and highlight common pitfalls such as poor injection quality, motion artifacts, and skull-induced aberration. The protocol is compatible with both cross-sectional and longitudinal studies and is particularly suited for investigating cerebrovascular alterations in models of aging, stroke, aneurysm, and neurodegenerative diseases. By combining depth penetration, high spatiotemporal resolution, and label-free vascular imaging, ULM offers a powerful tool for noninvasive brain microcirculation analysis in preclinical models.
- Open Access
Speed Vascular Patterns in the Spatial Navigation System
The hippocampal formation is central to spatial navigation, hosting neurons that encode position, direction, and speed. Yet, the brain-wide vascular dynamics supporting these processes remain poorly understood, especially during naturalistic behaviors. Here, we adapted functional ultrasound (fUS) imaging to examine how cerebral blood volume (CBV) changes relate to behavioral parameters in freely moving rats. High-resolution imaging of hippocampal-parahippocampal regions during open-field exploration reveals strong correlations between CBV dynamics and animal speed, with distinct regional activation patterns and temporal delays. Lagged general linear modeling uncovers information flow from the thalamus to parahippocampal regions, including the medial entorhinal cortex, and to hippocampal subfields (dentate gyrus, CA1–CA3), consistent with a hierarchical processing framework. The analysis also links CBV with angular head speed and the dorsal thalamus. Decoding analyses show that CBV signals not only encode speed precisely but also capture spatial features like proximity to walls and corners, even when univariate analyses do not. This decoding remains robust across animals, underscoring the universality of speed encoding in vascular dynamics. We also identify slow CBV oscillations in the hippocampus aligned with minute-scale speed fluctuations, suggesting a neurovascular signature of exploratory behavior. These findings reveal a hemodynamic signature of speed representation in the navigation system, arising from energy demands in a continuous attractor network model for path integration, where population activity and synaptic currents increase quadratically with animal speed as both peak firing rates and neuronal recruitment scale linearly with animal speed. Moreover, they highlight functional ultrasound imaging as a powerful approach for probing the hemodynamic basis of navigation.
Open AccessSpeed Vascular Patterns in the Spatial Navigation System
The hippocampal formation is central to spatial navigation, hosting neurons that encode position, direction, and speed. Yet, the brain-wide vascular dynamics supporting these processes remain poorly understood, especially during naturalistic behaviors. Here, we adapted functional ultrasound (fUS) imaging to examine how cerebral blood volume (CBV) changes relate to behavioral parameters in freely moving rats. High-resolution imaging of hippocampal-parahippocampal regions during open-field exploration reveals strong correlations between CBV dynamics and animal speed, with distinct regional activation patterns and temporal delays. Lagged general linear modeling uncovers information flow from the thalamus to parahippocampal regions, including the medial entorhinal cortex, and to hippocampal subfields (dentate gyrus, CA1–CA3), consistent with a hierarchical processing framework. The analysis also links CBV with angular head speed and the dorsal thalamus. Decoding analyses show that CBV signals not only encode speed precisely but also capture spatial features like proximity to walls and corners, even when univariate analyses do not. This decoding remains robust across animals, underscoring the universality of speed encoding in vascular dynamics. We also identify slow CBV oscillations in the hippocampus aligned with minute-scale speed fluctuations, suggesting a neurovascular signature of exploratory behavior. These findings reveal a hemodynamic signature of speed representation in the navigation system, arising from energy demands in a continuous attractor network model for path integration, where population activity and synaptic currents increase quadratically with animal speed as both peak firing rates and neuronal recruitment scale linearly with animal speed. Moreover, they highlight functional ultrasound imaging as a powerful approach for probing the hemodynamic basis of navigation.
- Open Access
- 10 April 2025
- Published by MIT Press in Imaging Neuroscience
- Vol. 3
Novel insights into vascular dysfunction in cuprizone-induced demyelination through functional ultrasound imaging
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), affecting 2.8 million people worldwide, that presents multiple features, one of which is demyelination. Although treatments exist to manage the condition, no cure has been found to stop the progression of neurodegeneration. To develop new treatments and investigate the multiple systems impacted by MS, new imaging technologies are needed at the preclinical stage. Functional ultrasound imaging (fUS) has recently emerged as a robust method to measure brain cerebral blood volume (CBV) dynamics as an indirect indicator of neural activity. This study aimed to quantify the amplitude of alteration of evoked hemodynamic response in the somatosensory cortex, and its potential link with demyelination in a mouse model of CNS demyelination induced by cuprizone. We demonstrate that extended demyelination leads to an increased hemodynamic response in the primary sensory cortex, both spatially and temporally, aligning with fMRI findings in MS patients. Second, using descriptors of the evoked cortical hemodynamic response, we demonstrate that certain parameters (the number of active pixels and the rise time) correlate with the level of Myelin Basic Protein in the primary sensory cortex and the thalamus, when taken together. Interestingly, the increased CBV is not associated with demyelination but instead reflects the well-documented vascular alteration described in MS. Moreover, these changes were absent in the thalamus, and in focalized demyelinated lesions induced by lysolecithin injection, suggesting the involvement of specific cortical mechanisms driven by oligodendrocyte depletion. In conclusion, our study introduces a novel, non-invasive functional approach for investigating vascular dysfunction in the context of MS, addressing an important yet understudied aspect in both pre-clinical and clinical research.
- 10 April 2025
- Published by MIT Press in Imaging Neuroscience
- Vol. 3
Open AccessNovel insights into vascular dysfunction in cuprizone-induced demyelination through functional ultrasound imaging
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), affecting 2.8 million people worldwide, that presents multiple features, one of which is demyelination. Although treatments exist to manage the condition, no cure has been found to stop the progression of neurodegeneration. To develop new treatments and investigate the multiple systems impacted by MS, new imaging technologies are needed at the preclinical stage. Functional ultrasound imaging (fUS) has recently emerged as a robust method to measure brain cerebral blood volume (CBV) dynamics as an indirect indicator of neural activity. This study aimed to quantify the amplitude of alteration of evoked hemodynamic response in the somatosensory cortex, and its potential link with demyelination in a mouse model of CNS demyelination induced by cuprizone. We demonstrate that extended demyelination leads to an increased hemodynamic response in the primary sensory cortex, both spatially and temporally, aligning with fMRI findings in MS patients. Second, using descriptors of the evoked cortical hemodynamic response, we demonstrate that certain parameters (the number of active pixels and the rise time) correlate with the level of Myelin Basic Protein in the primary sensory cortex and the thalamus, when taken together. Interestingly, the increased CBV is not associated with demyelination but instead reflects the well-documented vascular alteration described in MS. Moreover, these changes were absent in the thalamus, and in focalized demyelinated lesions induced by lysolecithin injection, suggesting the involvement of specific cortical mechanisms driven by oligodendrocyte depletion. In conclusion, our study introduces a novel, non-invasive functional approach for investigating vascular dysfunction in the context of MS, addressing an important yet understudied aspect in both pre-clinical and clinical research.
- Open Access
PhysiofUS : a tissue-motion based method for heart and breathing rate assessment in neurofunctional ultrasound imaging
Recent studies have shown growing evidence that brain function is closely synchronised with global physiological parameters. Heart rate is linked to various cognitive processes and previous research has also demonstrated a strong correlation between neuronal activity and breathing. These findings highlight the significance of monitoring these key physiological parameters during neuroimaging as they provide valuable insights into the overall brain function. Today, in neuroimaging, assessing these parameters required additional cumbersome devices or implanted electrodes. In this work, we performed ultrafast ultrasound imaging both in rodents and human neonates, and we extracted heart and breathing rates from local tissue motion assessed by raw ultrasound data processing. Such ‘PhysiofUS’ automatically select two specific and optimal brain regions with pulsatile tissue signals to monitor such parameters. We validated the correspondence of these periodic signals with heart and breathing rates assessed using gold-standard electrodes in various conditions in rodents. We also validated Physio-fUS imaging in a clinical environment using conventional ECG. We show the potential of fUS imaging as an integrative tool for simultaneously monitoring physiological parameters during neurofunctional imaging. Beyond the technological improvement, this innovation could enhance our understanding of the link between breathing, heart rate and neurovascular activity both anesthetised in preclinincal research and clinical functional ultrasound imaging.
Open AccessPhysiofUS : a tissue-motion based method for heart and breathing rate assessment in neurofunctional ultrasound imaging
Recent studies have shown growing evidence that brain function is closely synchronised with global physiological parameters. Heart rate is linked to various cognitive processes and previous research has also demonstrated a strong correlation between neuronal activity and breathing. These findings highlight the significance of monitoring these key physiological parameters during neuroimaging as they provide valuable insights into the overall brain function. Today, in neuroimaging, assessing these parameters required additional cumbersome devices or implanted electrodes. In this work, we performed ultrafast ultrasound imaging both in rodents and human neonates, and we extracted heart and breathing rates from local tissue motion assessed by raw ultrasound data processing. Such ‘PhysiofUS’ automatically select two specific and optimal brain regions with pulsatile tissue signals to monitor such parameters. We validated the correspondence of these periodic signals with heart and breathing rates assessed using gold-standard electrodes in various conditions in rodents. We also validated Physio-fUS imaging in a clinical environment using conventional ECG. We show the potential of fUS imaging as an integrative tool for simultaneously monitoring physiological parameters during neurofunctional imaging. Beyond the technological improvement, this innovation could enhance our understanding of the link between breathing, heart rate and neurovascular activity both anesthetised in preclinincal research and clinical functional ultrasound imaging.
- Open Access
Development of a novel, non-invasive and whole brain biomarker of demyelination in a mouse model of multiple sclerosis
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), affecting 2.8 million people worldwide, that presents multiple features, one of which is demyelination. Although treatments exist to manage the condition, no cure has been found to stop the progression of neurodegeneration. To develop new treatments and investigate the multiple systems impacted by MS, new imaging technologies are needed at the preclinical stage. Functional ultrasound imaging (fUS) has recently been demonstrated to robustly measure brain cerebral blood volume (CBV) dynamics as an indirect measure of neural activity. This study aimed at proposing a new biomarker of de- and/or re-myelination in a mouse model of MS induced by cuprizone. We demonstrate first that extended demyelination induces an increased hemodynamic response in the primary sensory cortex both spatially and temporally, which is consistent with fMRI data collected on MS patients. Second, using descriptors of the evoked hemodynamic response, we show that 3 of these descriptors allows the prediction of the level of myelin in the primary sensory cortex (p=5. 10 −5 ) and the thalamus (p=6. 10 −6 ). The development of such a non-invasive biomarker is crucial in the MS field as is provides an extremely useful tool for both disease follow-up and drug development. RESEARCH IN CONTEXT: Evidence before this study: Multiple sclerosis (MS) is an autoimmune neurodegenerative disorder of the central nervous system. It is the most common cause of neurological disability in young adults, affecting approximately 2.8 million worldwide. While the field of studies in MS has been very active at identifying the neurobiological cellular and molecular mechanisms underlying MS progression, the number of new treatments has been very limited so far, due to several factors, such as the lack of robust and non-invasive biomarkers of myelin loss in longitudinal studies (measurements during the development of the disease). Unfortunately, quantification of myelin loss, (one of the key neurobiological markers of MS progression) is classically performed post-mortem on fixed tissues, preventing longitudinal studies. Longitudinal follow up of an indirect measure of myelin loss is possible, using magnetic resonance imaging. However, the small size of rodent brains poses a challenge for conventional imaging techniques, requiring the use of high field magnet to achieve the necessary sensitivity and resolution. Added value of this study: In this study, using a sensitive neuroimaging technique, we developed a simple, non-invasive, predictive biomarker able to quantify the individual amount of myelin content consistently and accurately in brain structures in mice. Implications of all the available evidence: The development of such a biomarker is extremely important for the MS field as it will accelerate the pre-clinical tests for drug efficacy. The benefits provided by our biomarker encompass: 1) Enhanced sensitivity in individually quantifying myelin content, providing a more comprehensive assessment across diverse brain regions 2) Speeding up the process of the discovery, by reducing the number of animals required per group and 3) It will also likely lead to new scientific outcomes, as many more structures will be studied (most teams and drug compagnies only study the demyelination at the level of the corpus callosum). Finally, from a clinical perspective, given the brain alterations observed in this animal model closely mirror those observed in early stages in patients with MS, we anticipate our biomarker, with minimal additional refinements, to be readily applicable in clinical settings.
Open AccessDevelopment of a novel, non-invasive and whole brain biomarker of demyelination in a mouse model of multiple sclerosis
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), affecting 2.8 million people worldwide, that presents multiple features, one of which is demyelination. Although treatments exist to manage the condition, no cure has been found to stop the progression of neurodegeneration. To develop new treatments and investigate the multiple systems impacted by MS, new imaging technologies are needed at the preclinical stage. Functional ultrasound imaging (fUS) has recently been demonstrated to robustly measure brain cerebral blood volume (CBV) dynamics as an indirect measure of neural activity. This study aimed at proposing a new biomarker of de- and/or re-myelination in a mouse model of MS induced by cuprizone. We demonstrate first that extended demyelination induces an increased hemodynamic response in the primary sensory cortex both spatially and temporally, which is consistent with fMRI data collected on MS patients. Second, using descriptors of the evoked hemodynamic response, we show that 3 of these descriptors allows the prediction of the level of myelin in the primary sensory cortex (p=5. 10 −5 ) and the thalamus (p=6. 10 −6 ). The development of such a non-invasive biomarker is crucial in the MS field as is provides an extremely useful tool for both disease follow-up and drug development. RESEARCH IN CONTEXT: Evidence before this study: Multiple sclerosis (MS) is an autoimmune neurodegenerative disorder of the central nervous system. It is the most common cause of neurological disability in young adults, affecting approximately 2.8 million worldwide. While the field of studies in MS has been very active at identifying the neurobiological cellular and molecular mechanisms underlying MS progression, the number of new treatments has been very limited so far, due to several factors, such as the lack of robust and non-invasive biomarkers of myelin loss in longitudinal studies (measurements during the development of the disease). Unfortunately, quantification of myelin loss, (one of the key neurobiological markers of MS progression) is classically performed post-mortem on fixed tissues, preventing longitudinal studies. Longitudinal follow up of an indirect measure of myelin loss is possible, using magnetic resonance imaging. However, the small size of rodent brains poses a challenge for conventional imaging techniques, requiring the use of high field magnet to achieve the necessary sensitivity and resolution. Added value of this study: In this study, using a sensitive neuroimaging technique, we developed a simple, non-invasive, predictive biomarker able to quantify the individual amount of myelin content consistently and accurately in brain structures in mice. Implications of all the available evidence: The development of such a biomarker is extremely important for the MS field as it will accelerate the pre-clinical tests for drug efficacy. The benefits provided by our biomarker encompass: 1) Enhanced sensitivity in individually quantifying myelin content, providing a more comprehensive assessment across diverse brain regions 2) Speeding up the process of the discovery, by reducing the number of animals required per group and 3) It will also likely lead to new scientific outcomes, as many more structures will be studied (most teams and drug compagnies only study the demyelination at the level of the corpus callosum). Finally, from a clinical perspective, given the brain alterations observed in this animal model closely mirror those observed in early stages in patients with MS, we anticipate our biomarker, with minimal additional refinements, to be readily applicable in clinical settings.